Abstract:For the immune system to function properly, the activation of leukocytes must be tightly regulated. Failures of immune control mechanisms underlie the aberrant targeting of self‐antigens (i.e. autoimmunity) and the collateral damage of healthy tissues during excessive responses to infectious threats or the unnecessary immune mobilization against innocuous commensal microbes. Foxp3‐expressing CD4+ Regulatory T cells (Tregs) are a major cellular force working to prevent these pathologies of immune dysregulation. These cells characteristically exhibit multiple suppressive function that is absolutely required for the maintenance of immune homeostasis. However, these cells can hamper desirable anti‐tumor immune responses in cancer patients. Accordingly, a relative abundance of Tregs in the tumor microenvironment (TME) is a negative prognostic factor in many cancers. Treg‐depleting or antagonizing strategies show promise as potential interventions capable of unleashing anti‐tumor immunity from suppression. The characteristic gene expression and suppressive function of Tregs depend considerably on the stable expression and activity of the transcription factor FOXP3. While transcriptional regulation of the Foxp3gene has been studied in depth, both the expression and function of this factor are also modulated at the protein level. However, the molecular players involved in posttranslational FOXP3 regulation are just beginning to be elucidated. We have found that in the absence of the E3 ligase TRAF6 Tregs were dysfunctional in vivo. In these studies, mice with Treg‐restricted deletion of TRAF6 were highly resistant to implanted tumors and displayed enhanced anti‐tumor immunity. We further determined that FOXP3 undergoes lysine‐63 linked (K63) ubiquitination at lysine 262, and this posttranslational modification was mediated by TRAF6. When deprived of TRAF6 activity or rendered insensitive to K63 ubiquitination, FOXP3 displayed aberrant, perinuclear accumulation and disrupted regulatory function. Thus, K63 ubiquitination by TRAF6 ensures proper localization of FOXP3 and facilitates the transcription factor's gene‐regulating activity in Tregs. These results implicate TRAF6 as a key, hitherto unappreciated posttranslational facilitator of FOXP3 stabilization and Treg suppressive function that may be targeted by novel tolerance‐breaking immunotherapies to improve anti‐tumor immunity and combat disease progression in cancer patients.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

TRAF6-mediated Degradation of DOK3 is Required for Production of IL-6 and TNFα in TLR9 Signaling

Targeted Degradation of DOK3 Regulates LPS Responses and Endotoxin Tolerance (180.13)

TRAF6 promotes IL-4-induced M2 macrophage activation by stabilizing STAT6

A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages.

Stk38 protein kinase preferentially inhibits TLR9-activated inflammatory responses by promoting MEKK2 ubiquitination in macrophages

Differential Regulation of Interleukin 1 Receptor and Toll-like Receptor Signaling by MEKK3

E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages.

DOK3 negatively regulates LPS responses and endotoxin tolerance

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

Inducible Microrna-223 Down-Regulation Promotes Tlr-Triggered Il-6 And Il-1 Beta Production In Macrophages By Targeting Stat3

TRAF3/STAT6 axis regulates macrophage polarization and tumor progression

The 11S Proteasome Subunit PSME3 is a Positive Feedforward Regulator of NF-κB and Important for Host Defense Against Bacterial Pathogens.

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

E3 ligase RNF99 negatively regulates TLR-mediated inflammatory immune response via K48-linked ubiquitination of TAB2

Keratin 8 limits TLR-triggered inflammatory responses through inhibiting TRAF6 polyubiquitination

The E3 Ligase TRAF6 Directs FOXP3 Localization and Facilitates Treg Function Through K63‐type Ubiquitination

E3 Ligase Wwp2 Negatively Regulates Tlr3-Mediated Innate Immune Response By Targeting Trif For Ubiquitination And Degradation

TRAF3-interacting JNK-activating Modulator Promotes Inflammation by Stimulating Translocation of Toll-like Receptor 4 to Lipid Rafts

Cutting Edge: TRAF6 Mediates TLR/IL-1R Signaling–Induced Nontranscriptional Priming of the NLRP3 Inflammasome

DAP12 inhibition of LPS signaling in macrophages is mediated by DOK3

Poly(Di Center Dot Dc)-Induced Toll-Like Receptor 3 (Tlr3)-Mediated Activation Of Nf Kappa B And Map Kinase Is Through An Interleukin-1 Receptor-Associated Kinase (Irak)-Independent Pathway Employing The Signaling Components Tlr3-Traf6-Tak1-Tab2-Pkr